FE100726

FE100726 (Compound 39) is a Cholecystokinin 2 (CCK2) receptor agonist. FE100726 has a superior binding capacity on CCK2 receptor. FE100726 can induce gastric acid secretion in anaesthetized rat models. FE100726 can be used for diabetes research[1][2].

Product Specifications

CAS Number

[158459-39-3]

UNSPSC

12352211

Target

Cholecystokinin Receptor

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Metabolic Disease

Smiles

O=C(N(C1=CC=CC=C1C2)[C@H]2C(N([C@H](C3=CC=CC=C3)CC4)[C@H]4C(N(CC5=C(C6)C=CC=C5)[C@H]6C(N(CCC7)[C@@H]7C(O)=O)=O)=O)=O)OC(C)(C)C

Molecular Formula

C40H44N4O7

Molecular Weight

692.80

References & Citations

[1]Kalindjian SB, et al. Strategies for the design of non-peptide CCK2 receptor agonist and antagonist ligand. Curr Top Med Chem. 2007;7 (12) :1195-204. |[2]Semple G, et al. Identification and biological activity of novel peptidomimetic gastrin/CCK-B receptor agonists[J]. Bioorganic & Medicinal Chemistry Letters, 1996, 6 (24) : 2971-2976.